Amarin Files Definitive Proxy Materials and Mails Letter to Shareholders
Urges Shareholders to Vote AGAINST Sarissas Proposals on the WHITE Proxy Card
Highlights Significant Changes Implemented Over Last 18 Months New Strategy, New Leadership Team and Significantly Refreshed Board;
Transformation Underway with Strong Early Progress Advancing Geographic Expansion and Operational and Financial Excellence
Underscores Sarissas Misguided Proxy Contest Sarissa Has No Plan or New Ideas and Slate is Underqualified
Company Launches www.voteamarin.com, Featuring Videos with Chairman, Per Wold-Olsen, and CEO, Karim Mikhail and Providing Additional
Information for Shareholders
DUBLIN, Ireland and BRIDGEWATER. N.J. Jan. 31, 2023 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ: AMRN)
(Amarin or the Company) today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (SEC) in connection with its upcoming General Meeting of Shareholders scheduled to
be held on February 28, 2023. Shareholders of record as of January 23, 2023, will be entitled to vote at the meeting.
In conjunction with the
definitive proxy filing, Amarin has mailed a letter to the Companys shareholders and launched a new campaign website, www.voteamarin.com, featuring videos with the Companys Chairman of the Board, Per Wold-Olsen, and Chief
Executive Officer, Karim Mikhail. Amarins definitive proxy materials and other materials regarding the Board of Directors recommendation for the General Meeting can be found at www.voteamarin.com.
The full text of the letter being mailed to shareholders follows:
Dear Shareholder,
Your refreshed
Board of Directors has one clear priority: enhancing the value of your investment in Amarin in the short- and long-term. The last 18 months have been a story of transformation. When Karim Mikhail was appointed as CEO in August 2021,
Amarin was at the height of its challenges from generic competition to operational missteps.
Change was needed; we acted with
urgency to address Amarins challenges in a fast-moving market. We have a new leadership team with European commercial launch expertise and we instilled greater financial discipline across the organization. Coupled with our refreshed Board to
match the current needs of the Company, we are on our way to becoming a global, diversified cardiometabolic player, which we believe will drive significant long-term shareholder value. This is the NEW AMARIN.
Sarissa Capital Management an activist hedge fund has called a General Meeting in an attempt to remove our newly appointed Board
Chair and nearly double the size of the Amarin Board with seven of its own hand-picked candidates, three of whom are employees of Sarissa itself. We are asking you to support Amarins strategy to maximize shareholder value and vote
AGAINST all of Sarissas resolutions on the WHITE proxy card for three reasons: